Stock 1228 CANBRIDGE PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus CANbridge Pharmaceuticals Inc.

Equities

1228

KYG1821D1097

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:07 2024-06-05 am EDT 		5-day change 1st Jan Change
0.325 HKD -4.41% Intraday chart for CANbridge Pharmaceuticals Inc. +1.56% -67.17%
Apr. 23 Canbridge Pharmaceuticals Shelves Glioblastoma Drug After Phase II Clinical Trials MT
Apr. 22 CANbridge Pharmaceuticals Inc. Announces Results of CAN008 Phase II Clinical Trial for the Treatment of Glioblastoma Multiforme CI

Evolution of the average Target Price on CANbridge Pharmaceuticals Inc.

Price target over the last 5 years

History of analyst recommendation changes

8e3.YqLotkl5A7GKPQ6IKZ-K0vdJQp6avvrYR8450uWKBNo.UOql7AcMM8bjS1fKWtCzpYQveqv32aWvAp8IlqT8RalRwKrSOR9L49MMNg~cf0ab772c43e584f2fdb73e10fb77689

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.34 HKD
Average target price
12.3 HKD
Spread / Average Target
+3,517.65%
High Price Target
12.3 HKD
Spread / Highest target
+3,517.65%
Low Price Target
12.3 HKD
Spread / Lowest Target
+3,517.65%

Consensus detail

Consensus revision (last 18 months)

Ratings for CANbridge Pharmaceuticals Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 1228 Stock
  4. Consensus CANbridge Pharmaceuticals Inc.